Results
160
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
160 companies
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.095
7D
5.6%
1Y
58.3%
Medexus Pharmaceuticals
Market Cap: CA$90.6m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.74
7D
-6.8%
1Y
24.0%
Aurora Cannabis
Market Cap: CA$349.9m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$6.43
7D
2.6%
1Y
-25.1%
BioSyent
Market Cap: CA$128.9m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.40
7D
-2.1%
1Y
12.4%
1CM
Market Cap: CA$28.8m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.24
7D
0%
1Y
-41.7%
Innovotech
Market Cap: CA$13.2m
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
IOT
CA$0.28
7D
-6.7%
1Y
n/a
Oncolytics Biotech
Market Cap: CA$167.1m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONC
CA$1.65
7D
1.9%
1Y
16.2%
Captor Capital
Market Cap: CA$1.7m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.49
7D
-2.0%
1Y
96.0%
XORTX Therapeutics
Market Cap: CA$4.8m
A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.
XRTX
CA$1.34
7D
3.1%
1Y
-44.2%
Algernon Pharmaceuticals
Market Cap: CA$2.4m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.065
7D
0%
1Y
-43.5%
Organigram Global
Market Cap: CA$269.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.99
7D
-1.5%
1Y
-18.8%
Covalon Technologies
Market Cap: CA$71.0m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.56
7D
-6.9%
1Y
23.1%
Knight Therapeutics
Market Cap: CA$602.7m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$6.00
7D
-1.5%
1Y
5.3%
Microbix Biosystems
Market Cap: CA$40.8m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.29
7D
0%
1Y
-10.6%
High Tide
Market Cap: CA$273.9m
Engages in the cannabis retail business in Canada.
HITI
CA$3.29
7D
0.3%
1Y
24.6%
Sweet Earth Holdings
Market Cap: CA$6.6m
Does not have significant operations.
SE
CA$0.51
7D
0%
1Y
70.0%
Cronos Group
Market Cap: CA$1.1b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.84
7D
0.7%
1Y
-16.5%
Rakovina Therapeutics
Market Cap: CA$14.4m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.68
7D
-2.9%
1Y
-32.0%
Green Thumb Industries
Market Cap: CA$1.8b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$8.10
7D
-8.1%
1Y
-49.3%
NanoSphere Health Sciences
Market Cap: CA$359.6k
A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.
NSHS
CA$0.035
7D
0%
1Y
-30.0%
Simply Solventless Concentrates
Market Cap: CA$36.9m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.31
7D
29.2%
1Y
-10.1%
Satellos Bioscience
Market Cap: CA$104.0m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.58
7D
-1.7%
1Y
16.0%
Cardiol Therapeutics
Market Cap: CA$133.1m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.67
7D
-7.7%
1Y
-45.1%
Bright Minds Biosciences
Market Cap: CA$243.7m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$36.52
7D
4.5%
1Y
2,490.1%
Planet 13 Holdings
Market Cap: CA$81.3m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.28
7D
1.9%
1Y
-60.1%
SOL Global Investments
Market Cap: CA$14.2m
A private equity firm specializing in growth capital to small and mid-sized businesses.
SOL
CA$0.085
7D
-10.5%
1Y
30.8%
Medicure
Market Cap: CA$11.6m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.20
7D
0%
1Y
20.0%
Curaleaf Holdings
Market Cap: CA$1.0b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.68
7D
10.5%
1Y
-71.4%
Cipher Pharmaceuticals
Market Cap: CA$313.1m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$12.42
7D
-3.3%
1Y
38.5%
Medicenna Therapeutics
Market Cap: CA$70.0m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.80
7D
-3.6%
1Y
-59.0%
Rubicon Organics
Market Cap: CA$29.6m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.44
7D
-8.3%
1Y
-8.3%
BriaCell Therapeutics
Market Cap: CA$7.4m
A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$1.10
7D
-60.3%
1Y
-92.1%
Nextleaf Solutions
Market Cap: CA$10.9m
A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.
OILS
CA$0.06
7D
0%
1Y
-29.4%
RAMM Pharma
Market Cap: CA$1.2m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.01
7D
0%
1Y
-50.0%
iAnthus Capital Holdings
Market Cap: CA$33.7m
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
IAN
CA$0.005
7D
0%
1Y
-75.0%
Vaxil Bio
Market Cap: CA$547.9k
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.21
7D
5.0%
1Y
n/a